Senior Research Associate 2 (Neuroscience) at Eikon Therapeutics

New York, New York, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Biopharmaceutical, NeuroscienceIndustries

Requirements

Bachelor’s degree in Neuroscience, Stem Cell Biology, or a related field with a minimum of 6+ years of academic and/or industry experience; or Master’s degree with 4+ years of relevant experience
Extensive experience in cell culture techniques, including primary neuronal cultures, iPSC maintenance, and neuronal differentiation
Proficiency in molecular biology and biochemical assays, such as Western analysis, qRT-PCR, IPs, and ELISAs
Excellent interpersonal and communication skills with a collaborative, team-oriented mindset
Detail-oriented, highly organized, with the ability to manage multiple tasks and priorities simultaneously
Familiarity with laboratory safety protocols and adherence to regulatory guidelines

Responsibilities

Conduct cell culture experiments including utilizing cell lines, primary neuronal cultures, and iPSC-derived cells
Maintain and differentiate iPSCs into neuronal subtypes and perform detailed characterization
Perform routine biochemical and cell-based assays to support novel target validation in Parkinson’s disease
Involved in troubleshooting experiments, optimizing protocols, and addressing technical challenges to ensure high-quality data generation
Maintain organized and comprehensive records of experiments, results, and protocols in adherence to company standards and regulatory requirements
Support lab operations, including procurement, inventory management, and maintenance of laboratory equipment and supplies
Uphold a culture of safety by adhering to laboratory protocols and regulatory guidelines

Skills

stem cell biology

cellular neuroscience

iPSC differentiation

cell culture

primary neuronal cultures

biochemical assays

cell-based assays

target validation

Eikon Therapeutics

Biotech startup developing innovative medicines

About Eikon Therapeutics

Eikon Therapeutics focuses on discovering and developing new medicines in the pharmaceutical industry. The company employs advanced technologies to study biological systems, aiming to identify new drug targets by examining the dynamic aspects of biology rather than just static chemical processes. Their team consists of diverse professionals, including data scientists, chemists, and engineers, which allows them to combine science and engineering to create new therapies that aim to improve and extend life. A key feature of Eikon's approach is their proprietary single-molecule tracking (SMT) platform, which enables rapid visualization of protein movements in living cells. This technology, along with artificial intelligence and automation, allows for precise inventorying of molecular interactions. Eikon Therapeutics targets patients with serious diseases who need effective treatments, generating revenue through the development and commercialization of their therapies.

Hayward, CaliforniaHeadquarters

2019Year Founded

$750.8MTotal Funding

SERIES_CCompany Stage

AI & Machine Learning, BiotechnologyIndustries

201-500Employees

Benefits

401(k) Company Match

Medical (premiums covered by Eikon at 95%)

Dental Insurance

Vision Insurance

Mental Health Support

Unlimited Paid Time Off

Paid Holidays

Life Insurance

Enhanced Parental Leave

Daily subsidized lunch program

Risks

Competition from biotech unicorns like Abogen Biosciences is increasing.

Integrating new clinical-stage assets may delay drug development timelines.

Reliance on SMT technology risks obsolescence from emerging molecular biology technologies.

Differentiation

Eikon uses proprietary single-molecule tracking for real-time protein movement analysis.

The company integrates AI and automation for large-scale molecular interaction studies.

Eikon's diverse team combines expertise in science, engineering, and technology.

Upsides

Growing interest in SMT technology boosts Eikon's drug discovery potential.

Partnerships with AI firms enhance Eikon's drug candidate identification.

Rising demand for precision medicine aligns with Eikon's focus on dynamic biology.

Land your dream remote job 3x faster with AI

Try Jobo Free